Public Sector Pension Investment Board (PSP Investments)’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-203,472
Closed -$17M 1237
2023
Q4
$17M Buy
203,472
+84,820
+71% +$3.07M 0.13% 103
2023
Q3
$3.5M Sell
118,652
-51,112
-30% -$1.7M 0.03% 479
2023
Q2
$5.54M Buy
169,764
+3,330
+2% +$123K 0.04% 361
2023
Q1
$5.86M Sell
166,434
-5,727
-3% -$234K 0.04% 337
2022
Q4
$7.89M Sell
172,161
-407
-0.2% -$17.5K 0.06% 260
2022
Q3
$8.36M Buy
172,568
+14,013
+9% +$674K 0.07% 211
2022
Q2
$6.23M Buy
158,555
+1,993
+1% +$80.2K 0.05% 264
2022
Q1
$5.76M Sell
156,562
-14,290
-8% -$508K 0.04% 418
2021
Q4
$7.79M Buy
170,852
+2,100
+1% +$81K 0.04% 354
2021
Q3
$6.03M Buy
168,752
+22,160
+15% +$652K 0.03% 453
2021
Q2
$2.9M Buy
146,592
+660
+0.5% +$15.5K 0.02% 897
2021
Q1
$3.39M Sell
145,932
-10,630
-7% -$227K 0.02% 706
2020
Q4
$3.25M Buy
156,562
+470
+0.3% +$8.59K 0.02% 652
2020
Q3
$3.38M Buy
156,092
+23,750
+18% +$556K 0.03% 597
2020
Q2
$3.12M Hold
132,342
0.03% 556
2020
Q1
$1.56M Hold
132,342
0.02% 760
2019
Q4
$1.4M Sell
132,342
-15,100
-10% -$155K 0.01% 1259
2019
Q3
$1.68M Buy
147,442
+20,164
+16% +$253K 0.01% 1131
2019
Q2
$1.43M Buy
127,278
+79,400
+166% +$766K 0.01% 1137
2019
Q1
$387K Hold
47,878
﹤0.01% 1400
2018
Q4
$303K Buy
47,878
+12,700
+36% +$93.2K ﹤0.01% 1476
2018
Q3
$347K Buy
35,178
+2,937
+9% +$23.6K ﹤0.01% 1419
2018
Q2
$268K Hold
32,241
﹤0.01% 1350
2018
Q1
$232K Hold
32,241
﹤0.01% 1329
2017
Q4
$263K Hold
32,241
﹤0.01% 1367
2017
Q3
$467K Buy
32,241
+7,241
+29% +$98.9K ﹤0.01% 1167
2017
Q2
$303K Buy
+25,000
New +$347K ﹤0.01% 1170

Other funds holding CYTK

Public Sector Pension Investment Board (PSP Investments)'s CYTK Position: Q1 2024 in Review

Public Sector Pension Investment Board (PSP Investments) sold out of Cytokinetics (CYTK) in Q1 2024, closing a stake of 203,472 shares — an estimated $17M sold.

Public Sector Pension Investment Board (PSP Investments) first reported a position in CYTK in Q2 2017 and held it in 27 quarters. The position peaked at $17M in Q4 2023. 390 funds tracked by Wall St. Rank hold CYTK as of Q1 2024.

  • Public Sector Pension Investment Board (PSP Investments) reported no remaining Cytokinetics position as of Q1 2024 after selling out during the quarter.
  • Public Sector Pension Investment Board (PSP Investments) sold 203,472 Cytokinetics shares in Q1 2024, an estimated $17M.
  • Public Sector Pension Investment Board (PSP Investments) first reported a position in Cytokinetics in Q2 2017 and held it in 27 quarters.
  • Public Sector Pension Investment Board (PSP Investments)'s Cytokinetics position peaked at $17M in Q4 2023.
  • 390 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2024.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q1 2024, filed 14 May 2024.